Maarten Hoek
Company: Maze Therapeutics
Job title: Senior Vice President, Head of Research
Seminars:
Panel Discussion | Sharing Learnings from Successful Model Systems Used to Demonstrate Efficacy of Treatment in CKD & Accelerate Progression to the Clinic 1:30 pm
Ensuring confidence of in vivo or in vitro kidney tissue to behave like in the human condition Assessing the suitability of different models for testing specific targets Despite successes, outlining key aspects of preclinical model development in CKD that require further refinement to enhance translational capabilitiesRead more
day: Day 2 Track 1 PM
Discovering Distinct Genetic Signatures within Diverse CKD Populations for the Development of Precise Therapeutic Targets Tailored to Subtypes 11:00 am
Comprehending the genetic and phenotypic variability among various kidney diseases Uncovering underlying disease pathologies preceding the common pathways shared by all CKD subtypes Reconceptualizing distinct disease states through insights into genetic drivers specific to CKD subtypesRead more
day: Day 1 Track 1 AM
Leveraging the Availability of Advancing Technologies to Identify New Targets 10:25 am
day: Day 2 Track 1 AM